Development and validation of LC-MS/MS method for the quantification of oxcarbazepine in human plasma using an experimental design

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 1, 2008, Pages 28-33

  Srinubabu, Gedela ^a   Ratnam, Bandaru Veera Venkata ^b   Rao, Allam Appa ^a   Narasimha Rao, Medicherla ^a  

^a ANDHRA UNIVERSITY   (India)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Column liquid chromatography; Experimental design; Mass spectrometry; Oxcarbazepine; Robustness; Validation

Indexed keywords

ACETONITRILE; IMIPRAMINE; OXCARBAZEPINE; CARBAMAZEPINE; DRUG DERIVATIVE;

ACCURACY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SCREENING; DRUG SELECTIVITY; DRUG STABILITY; HUMAN; LIQUID CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ALGORITHM; ANALYSIS OF VARIANCE; BLOOD; MASS SPECTROMETRY; METHODOLOGY; THEORETICAL MODEL;

ALGORITHMS; ANALYSIS OF VARIANCE; CARBAMAZEPINE; HUMANS; MASS SPECTROMETRY; MODELS, THEORETICAL; RESEARCH DESIGN;

EID: 38049101087     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.28     Document Type: Article

References (24)

1. Kimiskidis V., Spanakis M., Niopas I., Kazis D., Gabrieli C., Kanaze F. I., Divanoglou D., J. Pharm. Biomed. Anal., 43, 763-769 (2007).
2. Juenke J. M., Brown P. I., Urry F. M., McMillin G. A., J. Chromatogr. Sci., 44, 45-51 (2006).
3. Levert H., Odou P., Robert H., J. Pharm. Biomed. Anal., 28, 517-523 (2002).
4. Kłys M., Rojek S., Bolechała F., J. Chromatogr. B: Anal. Technol. Biomed. Lift Sci., 825, 38-43 (2005).
5. Ma C. L., Jiao Z., Jie Y., Shi X. J., Chromatographia., 65, 267-272 (2007).
6. Yang J., Jiao Z., Shi X. J., Chinese Pharma. J., 41, 1899-1908 (2006).
7. Contin M., Balboni M., Callegati E., Candela C., Albani F., Riva R., Baruzzi A., J. Chromatogr. B: Anal. Technol. Biomed. Lift Sci., 828, 113-12 (2005).
8. Bugamelli F., Sabbioni C., Mandrioli R., Kenndler E., Albani F., Raggi M. A., Anal. Chim. Acta, 472, 1-8 (2002).
9. Levert H., Odou P., Robert H., Biomed. Chromatogr., 16, 19-26 (2002).
10. Khoschsorur G. A., Fruhwirth F., Halwachs-Baumann G., Chromatographia 54, 345-349 (2001).
11. Kumps A., J. Liq. Chromatogr., 7, 1235-1239 (1984).
12. Vaidyanathan S., Kell D. B., Goodacre R., Anal. Chem., 76, 5024-5032 (2004).
13. Riter L. S., Vitek O., Gooding K. M., Hodge B. D., Julian R. K., J. Mass Spectrom., 40, 565-579 (2005).
14. Charles L., Caloprisco S., Mohamed S., Sergent M., Int. J. Mass Spectrom., 11, 361-370 (2005).
15. Srinubabu G., Raju Ch. A. I., Sarath N., Kiran Kumar P., Seshagiri Rao J. V. L. N., Talanta, 71, 1424-1429 (2007).
16. Srinubabu G., Jaganbabu K., Sudharani B., Venugopal K., Girizasankar G., Seshagiri Rao J. V. L. N., Chromatographia, 64, 95-100 (2006).
17. Plackett R. L., Burman J. P., Biometrika, 33, 305-311 (1946).
18. Bose R. C., Kishen K., Sankhya, 21, 5-13 (1940).
19. Chen J., Sun D. X., Wu C. F. J., International Statistical Review, Special Issue on Statistics in Industry., 61, 131-145 (1993).
20. Validation of Analytical Procedures, Q2A Definitions and Terminology, Guidelines prepared within the International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use, ICH, 1995, pp. 1-5.
21. http://www.fda.gov/cder/guidance/4252fnl.pdf.
22. Box G. E., Hunter W. G., Hunter J. S., Hunter W. G., "Statistics for Experimenters: Design, Innovation, and Discovery," 2nd ed., John Wiley Sons, New York, 2005, pp. 134-143.
23. Douglas C. M., "Design and Analysis of Experiments," 5th ed., John Wiley Sons, New York, 2003, pp. 214-231.
24. Stat soft, Inc. (2001) Statistica data analysis system, Statistica software east 2300 14th street, Tulsa, Ok 74104.